Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-18-000029

CEO, President sold 6,000 shares at $3.48 ($20,867)

  • CEO, President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Mahesh V. CEO, President 2017-12-29 Option exercise +15,000 728,112 D
Patel Mahesh V. CEO, President 2017-12-29 Sale −6,000 $3.48 $20,867 722,112 D
Derivatives
Patel Mahesh V. CEO, President 2017-12-29 Option exercise · Restricted Stock Unit −15,000 45,000 D
Open-market sales · 6,000 sh · avg $3.48 · $20,867
Loading xslF345X03/doc4_5171.xml…